This Week
  • Phil Dolci, CEO of air gun manufacturer Crosman Corp., is aiming high.

  • For small businesses, diversification can be a strategy for growth, but not with some risk.

  • Renovation of the Tower at Midtown is "moving along quickly."

  • Three Brothers Wineries & Estates president sold Corsair Display Systems in 2004.

  • Jason Polasek, 27, goes after jobs that challenge him.

  • Meet the 2015 finalists for the RBJ Best of the Web.

Schumer: Valeant commits to keep, add jobs at B&L

Rochester Business Journal
August 15, 2013

Sen. Charles Schumer has been told there will be no more layoffs at Bausch & Lomb Inc., no further cuts to research and development and manufacturing, and as many as 50 research jobs will be transferred to Rochester from California, he said Thursday.

Schumer, D-N.Y., announced the commitments in a statement following a phone conversation with Valeant Pharmaceuticals International Inc. CEO Michael Pearson.

Valeant announced its $8.7 billion acquisition of Bausch & Lomb on May 27. The deal was consummated Aug. 6, with Valeant announcing 400 jobs cuts by November.

All existing vision care R&D will continue to be done in Rochester, Schumer said. In addition, 25 to 50 research jobs for the surgical intraocular lens business will be transferred here.

Valeant also will reconsider its plan to manufacturer its silicon hydrogel monthly contact lenses in Ireland rather than Rochester, Schumer said. That lens, commonly referred to as Zeus, was researched and developed in Rochester and its pilot manufacturing line is here.

(c) 2013 Rochester Business Journal. To obtain permission to reprint this article, call 585-546-8303 or email service@rbj.net.


What You're Saying 

There are no comments yet. Be the first to add yours!

Post Your Own Comment

 
Username:
Password:

Not registered? Sign up now!
 

To Do   Text Size
Post CommentPost A Comment eMail Size1
View CommentsView All Comments PrintPrint Size2
ReprintsReprints Size3
  • E-mailed
  • Commented
  • Viewed
RBJ   Google